Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DX25F6ABQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $114,858
Award facts
- Contract value 100% obligated
- $114,858.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded July 21, 2025, provides for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials to support the Defense Logistics Agency's pharmaceutical supply chain. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor to deliver this oncology medication with a firm fixed-price ceiling value of $114,858.10 and an ultimate completion date of August 11, 2025. The award carries no set-aside designation, indicating that DMS Pharmaceutical Group competed on an open basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, valued at $499,999,999 and effective through November 2026. The SPE2DB contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables, to support medical supply needs across Department of Defense healthcare facilities worldwide. As a critical supplier in the federal pharmaceutical distribution network, DMS Pharmaceutical Group provides direct delivery of prescription drugs and pharmacy services to military health installations nationwide.
Quick answers
Who was awarded contract SPE2DX25F6ABQ?
SPE2DX25F6ABQ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DX25F6ABQ worth?
The government has obligated $114,858 on SPE2DX25F6ABQ.
Is contract SPE2DX25F6ABQ an order under another contract?
Yes. SPE2DX25F6ABQ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ABQ competed?
The extent of competition for SPE2DX25F6ABQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award